112 related articles for article (PubMed ID: 7628854)
41. Human pancreatic adenocarcinomas express parathyroid hormone-related protein.
Bouvet M; Nardin SR; Burton DW; Behling C; Carethers JM; Moossa AR; Deftos LJ
J Clin Endocrinol Metab; 2001 Jan; 86(1):310-6. PubMed ID: 11232017
[TBL] [Abstract][Full Text] [Related]
42. Immunohistochemical study of parathyroid hormone-related protein in vesical transitional epithelium of patients with spinal cord injury.
Vaidyanathan S; McCreavy DT; McDicken IW; Soni BM; Mansour P; Wlodarski B; Carron JA; Fraser WD; Singh G; Sett P; Gallagher JA
Spinal Cord; 1999 Nov; 37(11):760-4. PubMed ID: 10578246
[TBL] [Abstract][Full Text] [Related]
43. Parathyroid hormone-related protein in gastric cancers with heterotopic ossification.
Yamamura-Idei Y; Kitazawa S; Kitazawa R; Fujimori T; Chiba T; Maeda S
Cancer; 1993 Sep; 72(6):1849-52. PubMed ID: 8364864
[TBL] [Abstract][Full Text] [Related]
44. Characterization of Notch Signalling Pathway Members in Normal Prostate, Prostatic Intraepithelial Neoplasia (PIN) and Prostatic Adenocarcinoma.
Soylu H; Acar N; Ozbey O; Unal B; Koksal IT; Bassorgun I; Ciftcioglu A; Ustunel I
Pathol Oncol Res; 2016 Jan; 22(1):87-94. PubMed ID: 26341090
[TBL] [Abstract][Full Text] [Related]
45. Passive immunization with anti-parathyroid hormone-related protein monoclonal antibody markedly prolongs survival time of hypercalcemic nude mice bearing transplanted human PTHrP-producing tumors.
Sato K; Yamakawa Y; Shizume K; Satoh T; Nohtomi K; Demura H; Akatsu T; Nagata N; Kasahara T; Ohkawa H
J Bone Miner Res; 1993 Jul; 8(7):849-60. PubMed ID: 8352067
[TBL] [Abstract][Full Text] [Related]
46. Molecular biology of prostatic intraepithelial neoplasia.
Bostwick DG; Pacelli A; Lopez-Beltran A
Prostate; 1996 Aug; 29(2):117-34. PubMed ID: 8700801
[TBL] [Abstract][Full Text] [Related]
47. Epigenetic events, remodelling enzymes and their relationship to chromatin organization in prostatic intraepithelial neoplasia and prostatic adenocarcinoma.
Mohamed MA; Greif PA; Diamond J; Sharaf O; Maxwell P; Montironi R; Young RA; Hamilton PW
BJU Int; 2007 Apr; 99(4):908-15. PubMed ID: 17378849
[TBL] [Abstract][Full Text] [Related]
48. Parathyroid hormone-related protein as a growth regulator of prostate carcinoma.
Dougherty KM; Blomme EA; Koh AJ; Henderson JE; Pienta KJ; Rosol TJ; McCauley LK
Cancer Res; 1999 Dec; 59(23):6015-22. PubMed ID: 10606251
[TBL] [Abstract][Full Text] [Related]
49. Microvessel density as a molecular marker for identifying high-grade prostatic intraepithelial neoplasia precursors to prostate cancer.
Sinha AA; Quast BJ; Reddy PK; Lall V; Wilson MJ; Qian J; Bostwick DG
Exp Mol Pathol; 2004 Oct; 77(2):153-9. PubMed ID: 15351240
[TBL] [Abstract][Full Text] [Related]
50. Hypercalcemia due to parathyroid hormone-related protein secretion by melanoma.
Yeung SC; Eton O; Burton DW; Deftos LJ; Vassilopoulou-Sellin R; Gagel RF
Horm Res; 1998; 49(6):288-91. PubMed ID: 9623520
[TBL] [Abstract][Full Text] [Related]
51. Androgen receptor expression in prostatic intraepithelial neoplasia and cancer.
Sweat SD; Pacelli A; Bergstralh EJ; Slezak JM; Bostwick DG
J Urol; 1999 Apr; 161(4):1229-32. PubMed ID: 10081875
[TBL] [Abstract][Full Text] [Related]
52. Cathepsin B in angiogenesis of human prostate: an immunohistochemical and immunoelectron microscopic analysis.
Sinha AA; Gleason DF; Staley NA; Wilson MJ; Sameni M; Sloane BF
Anat Rec; 1995 Mar; 241(3):353-62. PubMed ID: 7538734
[TBL] [Abstract][Full Text] [Related]
53. Immunohistochemical analysis of low-grade and high-grade prostate carcinoma: relative changes of parathyroid hormone-related protein and its parathyroid hormone 1 receptor, osteoprotegerin and receptor activator of nuclear factor-kB ligand.
Pérez-Martínez FC; Alonso V; Sarasa JL; Nam-Cha SG; Vela-Navarrete R; Manzarbeitia F; Calahorra FJ; Esbrit P
J Clin Pathol; 2007 Mar; 60(3):290-4. PubMed ID: 16775117
[TBL] [Abstract][Full Text] [Related]
54. Aberrant expression of CARM1, a transcriptional coactivator of androgen receptor, in the development of prostate carcinoma and androgen-independent status.
Hong H; Kao C; Jeng MH; Eble JN; Koch MO; Gardner TA; Zhang S; Li L; Pan CX; Hu Z; MacLennan GT; Cheng L
Cancer; 2004 Jul; 101(1):83-9. PubMed ID: 15221992
[TBL] [Abstract][Full Text] [Related]
55. Transforming growth factor-beta 1: comparative immunohistochemical localization in human primary and metastatic prostate cancer.
Eastham JA; Truong LD; Rogers E; Kattan M; Flanders KC; Scardino PT; Thompson TC
Lab Invest; 1995 Nov; 73(5):628-35. PubMed ID: 7474936
[TBL] [Abstract][Full Text] [Related]
56. The distribution of PAX-2 immunoreactivity in the prostate gland, seminal vesicle, and ejaculatory duct: comparison with prostatic adenocarcinoma and discussion of prostatic zonal embryogenesis.
Quick CM; Gokden N; Sangoi AR; Brooks JD; McKenney JK
Hum Pathol; 2010 Aug; 41(8):1145-9. PubMed ID: 20413145
[TBL] [Abstract][Full Text] [Related]
57. Expression of prostate specific membrane antigen (PSMA) in prostatic adenocarcinoma and prostatic intraepithelial neoplasia.
Marchal C; Redondo M; Padilla M; Caballero J; Rodrigo I; García J; Quian J; Boswick DG
Histol Histopathol; 2004 Jul; 19(3):715-8. PubMed ID: 15168332
[TBL] [Abstract][Full Text] [Related]
58. A novel parathyroid hormone-related protein: role in pathology and physiology.
Martin TJ; Ebeling PR
Prog Clin Biol Res; 1990; 332():1-37. PubMed ID: 2184438
[TBL] [Abstract][Full Text] [Related]
59. Ep-Cam levels in prostatic adenocarcinoma and prostatic intraepithelial neoplasia.
Poczatek RB; Myers RB; Manne U; Oelschlager DK; Weiss HL; Bostwick DG; Grizzle WE
J Urol; 1999 Oct; 162(4):1462-6. PubMed ID: 10492238
[TBL] [Abstract][Full Text] [Related]
60. In situ hybridization of parathyroid hormone-related protein in normal skin, skin tumors, and gynecological cancers using digoxigenin-labeled probes and antibody enhancement.
Danks JA; McHale JC; Clark SP; Chou ST; Scurry JP; Ingleton PM; Martin TJ
J Histochem Cytochem; 1995 Jan; 43(1):5-10. PubMed ID: 7822764
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
